| Design, synthesis, molecular modeling, in vivo studies and anticancer evaluation of quinazolin-4 (3H)-one derivatives as potential VEGFR-2 inhibitors and apoptosis inducers HA Mahdy, MK Ibrahim, AM Metwaly, A Belal, ABM Mehany, ... Bioorganic Chemistry 94, 103422, 2020 | 135 | 2020 |
| Design, synthesis, molecular modeling and anti-proliferative evaluation of novel quinoxaline derivatives as potential DNA intercalators and topoisomerase II inhibitors MK Ibrahim, MS Taghour, AM Metwaly, A Belal, ABM Mehany, ... European journal of medicinal chemistry 155, 117-134, 2018 | 111 | 2018 |
| Discovery of new pyrimidine-5-carbonitrile derivatives as anticancer agents targeting EGFR WT and EGFR T790M AA Nasser, IH Eissa, MR Oun, MA El-Zahabi, MS Taghour, A Belal, ... Organic & biomolecular chemistry 18 (38), 7608-7634, 2020 | 110 | 2020 |
| Design, synthesis, molecular docking and biological activity evaluation of some novel indole derivatives as potent anticancer active agents and apoptosis inducers AMS El-Sharief, YA Ammar, A Belal, MAMS El-Sharief, YA Mohamed, ... Bioorganic chemistry 85, 399-412, 2019 | 95 | 2019 |
| Design, synthesis, antiproliferative activity, molecular docking and cell cycle analysis of some novel (morpholinosulfonyl) isatins with potential EGFR inhibitory activity YA Ammar, AMS El-Sharief, A Belal, SY Abbas, YA Mohamed, ... European journal of medicinal chemistry 156, 918-932, 2018 | 86 | 2018 |
| Design, molecular docking, in vitro, and in vivo studies of new quinazolin-4 (3H)-ones as VEGFR-2 inhibitors with potential activity against hepatocellular carcinoma IH Eissa, MK Ibrahim, AM Metwaly, A Belal, ABM Mehany, AA Abdelhady, ... Bioorganic Chemistry 107, 104532, 2021 | 77 | 2021 |
| Design, eco-friendly synthesis, molecular modeling and anticancer evaluation of thiazol-5 (4 H)-ones as potential tubulin polymerization inhibitors targeting the colchicine … AM El-Naggar, IH Eissa, A Belal, AA El-Sayed RSC advances 10 (5), 2791-2811, 2020 | 66 | 2020 |
| Discovery and antiproliferative evaluation of new quinoxalines as potential DNA intercalators and topoisomerase II inhibitors IH Eissa, AM Metwaly, A Belal, ABM Mehany, RR Ayyad, K El‐Adl, ... Archiv der Pharmazie 352 (11), 1900123, 2019 | 65 | 2019 |
| Design and Synthesis of New Quinoxaline Derivatives as Potential Histone Deacetylase Inhibitors Targeting Hepatocellular Carcinoma: In Silico, In Vitro, and SAR … C Ma, MS Taghour, A Belal, ABM Mehany, N Mostafa, A Nabeeh, IH Eissa, ... Frontiers in chemistry 9, 725135, 2021 | 61 | 2021 |
| Design, synthesis, molecular modeling, in vivo studies and anticancer activity evaluation of new phthalazine derivatives as potential DNA intercalators and topoisomerase II … AGA El-Helby, H Sakr, RR Ayyad, HA Mahdy, MM Khalifa, A Belal, ... Bioorganic chemistry 103, 104233, 2020 | 61 | 2020 |
| Pyrrolizines: Promising scaffolds for anticancer drugs A Belal, BEDM El-Gendy Bioorganic & Medicinal Chemistry 22 (1), 46-53, 2014 | 60 | 2014 |
| New benzothiazole/benzoxazole-pyrazole hybrids with potential as COX inhibitors: design, synthesis and anticancer activity evaluation A Belal, MA Abdelgawad Research on Chemical Intermediates 43, 3859-3872, 2017 | 54 | 2017 |
| Synthesis, Anti‐B reast Cancer Activity, and Molecular Modeling of Some Benzothiazole and Benzoxazole Derivatives MA Abdelgawad, A Belal, HA Omar, L Hegazy, ME Rateb Archiv der Pharmazie 346 (7), 534-541, 2013 | 54 | 2013 |
| Development of adamantane scaffold containing 1, 3, 4-thiadiazole derivatives: Design, synthesis, anti-proliferative activity and molecular docking study targeting EGFR MMS Wassel, YA Ammar, GAME Ali, A Belal, ABM Mehany, A Ragab Bioorganic Chemistry 110, 104794, 2021 | 52 | 2021 |
| Design, synthesis, antiproliferative evaluation, and molecular docking study of new quinoxaline derivatives as apoptotic inducers and EGFR inhibitors EA Fayed, YA Ammar, MA Saleh, AH Bayoumi, A Belal, ABM Mehany, ... Journal of Molecular Structure 1236, 130317, 2021 | 51 | 2021 |
| Design, synthesis, antimicrobial activity and molecular docking studies of some novel di-substituted sulfonylquinoxaline derivatives YA Ammar, AA Farag, AM Ali, A Ragab, AA Askar, DM Elsisi, A Belal Bioorganic Chemistry 104, 104164, 2020 | 46 | 2020 |
| Design, synthesis, molecular docking and antiproliferative activity of some novel benzothiazole derivatives targeting EGFR/HER2 and TS KRA Abdellatif, A Belal, MT El-Saadi, NH Amin, EG Said, LR Hemeda Bioorganic Chemistry 101, 103976, 2020 | 43 | 2020 |
| Design, synthesis and molecular docking of new fused 1H-pyrroles, pyrrolo[3,2-d]pyrimidines and pyrrolo[3,2-e][1, 4]diazepine derivatives as potent EGFR/CDK2 … A Belal, NM Abdel Gawad, ABM Mehany, MAS Abourehab, H Elkady, ... Journal of enzyme inhibition and medicinal chemistry 37 (1), 1884-1902, 2022 | 37 | 2022 |
| Multi-phase in silico discovery of potential SARS-CoV-2 RNA-dependent RNA polymerase inhibitors among 3009 clinical and FDA-approved related drugs EB Elkaeed, H Elkady, A Belal, BA Alsfouk, TH Ibrahim, M Abdelmoaty, ... Processes 10 (3), 530, 2022 | 37 | 2022 |
| Design and synthesis of novel benzoazoninone derivatives as potential CBSIs and apoptotic inducers: in vitro, in vivo, molecular docking, molecular dynamics, and SAR studies MM Hammouda, AA Elmaaty, MS Nafie, M Abdel-Motaal, NS Mohamed, ... Bioorganic Chemistry 127, 105995, 2022 | 36 | 2022 |
Khaled R. A. AbdellatifIbn Sina National College for Medical Studies, Jeddah, Faculty of Pharmacy Beni-Suef Universityبريد إلكتروني تم التحقق منه على pharm.bsu.edu.eg
